Medicines
Malignant Disease and Immunosuppression
Cytotoxic drugs
Topotecan

Topotecan

Malignant Disease and Immunosuppression Cytotoxic drugs BNF 0801050AF

Data updated May 2023 Download CSV

1items

Dispensed in May 2023

0items

Rolling 12 months

£105

Net ingredient cost · May 2023

Figure 1. Topotecan: national items dispensed by month

Source: NHSBSA Prescription Cost Analysis, to May 2023

Download CSV

Embed this chart

<iframe src="https://pharmainsight.co.uk/embed/medicines/topotecan-0801050af" width="100%" height="280" style="border:0" loading="lazy" title="Topotecan: NHS prescribing in England — PharmaInsight"></iframe>
<p style="font-size:13px;margin-top:4px">Chart: <a href="https://pharmainsight.co.uk/medicines/topotecan-0801050af">PharmaInsight</a> · Data: NHSBSA Prescription Cost Analysis</p>

Free to reuse with the credit line above.

At a glance

Therapeutic class Cytotoxic drugs
Presentations 1 shown
Average cost / item £105.00

What this is

Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Where Topotecan is dispensed

The regions and dispensing practices with the highest Topotecan volumes.

Top regions

NHS West Yorkshire Integrated Care Board 1

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

Compare Topotecan with

Other medicines in the same BNF section, by prescribing volume.

Topotecan vs Fluorouracil (Antimetabolites) Topotecan vs Hydroxycarbamide Topotecan vs Mercaptopurine Topotecan vs Methotrexate Topotecan vs Calcium folinate

Download this data

The monthly series for Topotecan is in this page's CSV. For the ranked national series across every medicine, with the method and caveats documented, see the most-prescribed medicines dataset in our open data catalogue.